Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Marek Minarik"'
Autor:
Lucie Benesova, Renata Ptackova, Tereza Halkova, Anastasiya Semyakina, Martin Svaton, Ondrej Fiala, Milos Pesek, Marek Minarik
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Background: Observation of anticancer therapy effect by monitoring of minimal residual disease (MRD) is becoming an important tool in management of non-small cell lung cancer (NSCLC). The approach is based on periodic detection and quantification of
Externí odkaz:
https://doaj.org/article/089f2946a5c14fe4914df4dad2fe7b16
Autor:
Filip Pazdirek, Marek Minarik, Lucie Benesova, Tereza Halkova, Barbora Belsanova, Milan Macek, Lubomír Stepanek, Jiri Hoch
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Introduction: Patients with locally advanced rectal cancer (LARC) are undergoing neoadjuvant chemoradiotherapy (NCRT) prior to surgery. Although in some patients the NCRT is known to prevent local recurrence, it is also accompanied by side effects. A
Externí odkaz:
https://doaj.org/article/87bd56c11fdb4bdcacb54b66e5c569be
Autor:
Petra Minarikova, Lucie Benesova, Tereza Halkova, Barbora Belsanova, Inna Tuckova, Frantisek Belina, Ladislav Dusek, Miroslav Zavoral, Marek Minarik
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Background. Gastric cancer is known for a notable variety in the course of the disease. Clinical factors, such as tumor stage, grade, and localization, are key in patient survival. It is expected that molecular factors such as somatic mutations and g
Externí odkaz:
https://doaj.org/article/f73afe54865a4b218fb9985bf696dc54
Publikováno v:
Gastroenterology Research and Practice, Vol 2015 (2015)
Pancreatic cancer is one of the most fatal malignancies with increasing incidence and high mortality. Possibilities for early diagnosis are limited and there is currently no efficient therapy. Molecular markers that have been introduced into diagnosi
Externí odkaz:
https://doaj.org/article/d1750e55621d44599c347176be5a137b
Autor:
ONDREJ FIALA, JAN BAXA, MARTIN SVATON, LUCIE BENESOVA, RENATA PTACKOVA, TEREZA HALKOVA, MAREK MINARIK, PETR HOSEK, MARCELA BURESOVA, JINDRICH FINEK, JIRI FERDA, MILOS PESEK
Publikováno v:
Cancer Genomics - Proteomics. 19:270-281
Autor:
Marcela Buresova, Lucie Benesova, Marek Minarik, Renata Ptackova, Tereza Halkova, Petr Hosek, Jan Baxa, Milos Pesek, Martin Svaton, Ondrej Fiala
Publikováno v:
Journal of Cancer. 14(1)
Publikováno v:
Gastroenterologie a hepatologie. 74:393-403
Neoadjuvant chemotherapy in combination with radiation is currently the standard of care for patients with locally advanced rectal cancer. The main purpose of the treatment is to reduce the risk of recurrence, however at the same time it may be accom
Autor:
Marek Minarik, Filip Pazdirek, Miroslav Ryska, Milan Blaha, Lucie Benesova, Anastasiya Semyakina, Jiří Pudil, Jiří Hoch, J. Simsa, Kateřina Menclová, Tereza Halkova, Renata Ptackova, Miroslav Levý
Publikováno v:
World Journal of Gastroenterology
BACKGROUND One of the most notable applications for circulating tumor DNA (ctDNA) detection in peripheral blood of patients with metastatic colorectal cancer (mCRC) is a long-term postoperative follow-up. Sometimes referred to as a “liquid (re)biop
Autor:
Ondrej, Fiala, Jan, Baxa, Martin, Svaton, Lucie, Benesova, Renata, Ptackova, Tereza, Halkova, Marek, Minarik, Petr, Hosek, Marcela, Buresova, Jindrich, Finek, Jiri, Ferda, Milos, Pesek
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: Circulating tumour DNA (ctDNA) represents an emerging biomarker in non-small cell lung cancer (NSCLC). We focused on the combination of ctDNA and positron emission tomography/computed tomography (PET/CT) in the follow-up monitoring of
Publikováno v:
Journal of Chromatography A. 1554:1-7
A new instrumental approach to recycling HPLC is described. The concept is based on fast reintroduction of incremental peak sections back onto the separation column. The re-circulation is performed within a closed loop containing only the column and